Real-World Data Confirm KRd Safety, Efficacy in RRMM

November 26th 2020, 12:30pm


New real-world data confirms that carfilzomib, lenalidomide, and dexamethasone (KRd) are a safe and effective option for patients with relapsed or refractory multiple myeloma.

Association Between Clogged Arteries and Body Size Phenotype? Study Finds, “It Varies”

November 25th 2020, 4:30pm


Visual Field Defects Are Consistent in Macular Measurements Among Those With Glaucoma, High Myopia

November 25th 2020, 3:30pm


Findings published in BMC Ophthalmology suggest that during diagnosis and follow-up of glaucoma with high myopia, more attention ought to be focused on structure and functional defects in macular areas.

A Timeline of COVID-19 Developments in 2020

November 25th 2020, 1:32pm


The entire year has been dominated by the coronavirus disease 2019 (COVID-19) and many countries in the world are experiencing second or third waves of COVID-19 cases as the weather turns colder. Here, we take an updated look at how this pandemic evolved and progressed thus far in 2020.

Study of 2 Treatments for PAH Finds 1 Reduces Risk of Hospitalization

November 25th 2020, 1:00pm


Compared with treprostinil, selexipag carried a 47% reduced risk of pulmonary arterial hypertension (PAH)-related hospitalization and 46% reduced risk of all-cause hospitalization.

FDA Approves Drug for Progeria, a Rare Disease Causing Rapid Aging in Children

November 23rd 2020, 5:56pm


Research behind the therapy could lead to other discoveries about heart disease as well as the aging process.

Late Effects of Therapy Plague Many Patients Who Survived AML as Youths, Young Adults

November 23rd 2020, 12:30pm


Most patients who are diagnosed with acute myeloid leukemia are in middle or old age. The relatively small number who are diagnosed earlier in life can be subject to long-term health risks due to their treatment.

Commentary Examines What Is Known About BRCA1 Mutations Compared With BRCA2 in Prostate Cancer

November 21st 2020, 4:10pm


Authors in the Journal of Clinical Oncology discuss hypotheses on the differences in mutations and implications for treatment with PARP inhibitors.

Imaging Study Shows Upper Leg Involvement in SMA

November 21st 2020, 1:30pm


Using DIXON, T2 mapping, and diffusion tensor imaging, the researchers obtained quantitative MRI for 31 patients with spinal muscular atrophy (SMA) types 2 and 3.

Is a Brighter Future Possible for PARP Inhibitor Use in Prostate Cancer?

November 20th 2020, 9:48pm


Mounting evidence is supporting the use of poly ADP-ribose polymerase (PARP) inhibitors in prostate cancer, according to a new study.